✦ LIBER ✦

Clinical evaluation of endoscopic injection sclerotherapy for bleeding esophageal varices in liver cirrhosis with hepatocellular carcinoma

✍ Scribed by Nakashima, Masaomi ;Yoshida, Ken ;Izuno, Kiyonori ;Murata, Hiroshi ;Fujiyama, Shigetoshi ;Sato, Tatsuo

Publisher: Springer-Verlag
Year: 1991
Tongue: English
Weight: 195 KB
Volume: 26
Category: Article
ISSN: 0435-1339
DOI: 10.1007/bf02779259

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Endoscopic injection sclerotherapy for e

Endoscopic injection sclerotherapy for esophageal varices associated with concomintant portal venous thrombus of hepatocellular carcinoma

✍ Masayuki Ohta; Makoto Hashizume; Morimasa Tomikawa; Tatsuro Kamakura; Kouhei Aka 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB

Between 1983 and 1994, we treated 51 patients with esophageal varices and portal trunk and main branch invasion of hepatocellular carcinoma, using endoscopic injection sclerotherapy . Variceal bleeding was controlled in 28 of 29 patients (96.6%), esophageal varices were completely eradicated in 28 (

Significance of hemostatic molecular mar

Significance of hemostatic molecular markers during disseminated intravascular coagulation in patients with liver cirrhosis treated by endoscopic embolization for esophageal varices

✍ Tetsuji Koyama; Eizo Kakishita; Yoshiyuki Nakai; Eizo Okamoto 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 3 views

Sclerotherapy vs. esophageal transection

Sclerotherapy vs. esophageal transection vs. distal splenorenal shunt for the clinical management of esophageal varices in patients with child class A and B liver function: A prospective randomized trial

✍ Seigo Kitano; Yasunori Iso; Makoto Hashizume; Hirohiko Yamaga; Nobuhiro Koyanagi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 691 KB

Ninety-six patients with good liver function (Child class A or B) and esophageal varices were randomly assigned to one of three groups given different treatments: endoscopic injection sclerotherapy (n = 32), esophageal transection (n = 32) or distal splenorenal shunt (n = 32). Five patients (5.2%) h